1st Global Advisors Inc. bought a new stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,978 shares of the medical instruments supplier’s stock, valued at approximately $281,000.

Other hedge funds have also made changes to their positions in the company. Acrospire Investment Management LLC bought a new stake in shares of West Pharmaceutical Services during the 2nd quarter valued at $113,000. Citigroup Inc. boosted its holdings in shares of West Pharmaceutical Services by 95.1% during the 2nd quarter. Citigroup Inc. now owns 1,569 shares of the medical instruments supplier’s stock valued at $148,000 after buying an additional 765 shares in the last quarter. Wolverine Trading LLC bought a new stake in shares of West Pharmaceutical Services during the 2nd quarter valued at $200,000. Nomura Holdings Inc. bought a new stake in shares of West Pharmaceutical Services during the 2nd quarter valued at $201,000. Finally, Bradley Foster & Sargent Inc. CT bought a new stake in shares of West Pharmaceutical Services during the 2nd quarter valued at $212,000. Hedge funds and other institutional investors own 90.70% of the company’s stock.

WST has been the topic of a number of research reports. Jefferies Group LLC upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and boosted their target price for the company from $96.00 to $115.00 in a report on Friday, September 15th. BidaskClub cut shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Zacks Investment Research cut shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research note on Tuesday, July 4th. Bank of America Corporation cut shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price target on the stock. in a research note on Tuesday. Finally, Stephens started coverage on shares of West Pharmaceutical Services in a research note on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 price target on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $104.00.

West Pharmaceutical Services, Inc. (WST) opened at 92.28 on Friday. The company has a 50-day moving average of $93.42 and a 200-day moving average of $91.55. West Pharmaceutical Services, Inc. has a 52 week low of $70.17 and a 52 week high of $99.91. The company has a market cap of $6.83 billion, a PE ratio of 39.61 and a beta of 1.12.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. West Pharmaceutical Services had a return on equity of 14.02% and a net margin of 11.42%. The company had revenue of $397.60 million for the quarter, compared to the consensus estimate of $406.00 million. During the same quarter last year, the company earned $0.59 earnings per share. The firm’s revenue for the quarter was up 2.5% compared to the same quarter last year. On average, equities analysts expect that West Pharmaceutical Services, Inc. will post $2.67 EPS for the current year.

TRADEMARK VIOLATION WARNING: This news story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/10/20/1st-global-advisors-inc-takes-281000-position-in-west-pharmaceutical-services-inc-wst.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Stock Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related stocks with our FREE daily email newsletter.